Meag Munich Ergo, Kapitalanlagegesellschaft Mb H Abb Vie Inc. Transaction History

Meag Munich Ergo, Kapitalanlagegesellschaft Mb H

$3.1 Billion
Q3 2024

A detailed history of Meag Munich Ergo, Kapitalanlagegesellschaft Mb H transactions in Abb Vie Inc. stock. As of the latest transaction made, Meag Munich Ergo, Kapitalanlagegesellschaft Mb H holds 172,566 shares of ABBV stock, worth $29.6 Million. This represents 1.1% of its overall portfolio holdings.

Number of Shares

172,566

Previous 168,664 2.31%

Holding current value

$29.6 Million

Previous $28.9 Million 17.8%

% of portfolio

1.1%

Previous 0.98%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	BUY	$163.84 - $199.33 $639,303 - $777,785	3,902 Added 2.31%	172,566 $34.1 Million
Q2 2024 Aug 01, 2024	BUY	$154.79 - $180.76 $12 Million - $14.1 Million	77,785 Added 85.59%	168,664 $28.9 Million
Q1 2024 Apr 18, 2024	SELL	$159.82 - $182.1 $619,781 - $706,183	-3,878 Reduced 4.09%	90,879 $16.5 Million
Q4 2023 Jan 19, 2024	BUY	$137.6 - $154.97 $236,672 - $266,548	1,720 Added 1.85%	94,757 $14.7 Million
Q3 2023 Oct 25, 2023	BUY	$133.59 - $154.65 $25,515 - $29,538	191 Added 0.21%	93,037 $13.9 Million
Q2 2023 Jul 14, 2023	SELL	$132.51 - $164.9 $82,023 - $102,073	-619 Reduced 0.66%	92,846 $12.5 Million
Q1 2023 Apr 20, 2023	BUY	$144.61 - $166.54 $6.23 Million - $7.17 Million	43,055 Added 85.41%	93,465 $14.9 Million
Q4 2022 Jan 19, 2023	SELL	$138.31 - $165.87 $35,130 - $42,130	-254 Reduced 0.5%	50,410 $8.15 Million
Q3 2022 Oct 18, 2022	BUY	$134.21 - $153.93 $41,739 - $47,872	311 Added 0.62%	50,664 $6.8 Million
Q2 2022 Jul 19, 2022	BUY	$137.62 - $174.96 $6.86 Million - $8.72 Million	49,853 Added 9970.6%	50,353 $7.71 Million
Q1 2022 Apr 13, 2022	SELL	$131.98 - $163.75 $389,868 - $483,717	-2,954 Reduced 85.52%	500 $82,000
Q2 2021 Jul 16, 2021	SELL	$105.21 - $117.21 $7.04 Million - $7.84 Million	-66,923 Reduced 95.09%	3,454 $389,000
Q1 2021 Apr 20, 2021	BUY	$102.3 - $112.62 $5.18 Million - $5.7 Million	50,634 Added 256.47%	70,377 $7.62 Million
Q4 2020 Jan 20, 2021	SELL	$80.49 - $108.67 $550,793 - $743,628	-6,843 Reduced 25.74%	19,743 $2.08 Million
Q3 2020 Oct 20, 2020	SELL	$85.91 - $100.83 $1.41 Million - $1.65 Million	-16,383 Reduced 38.13%	26,586 $2.33 Million
Q1 2020 Apr 23, 2020	SELL	$64.5 - $97.79 $2.23 Million - $3.39 Million	-34,635 Reduced 44.63%	42,969 $3.27 Million
Q4 2019 Jan 17, 2020	SELL	$72.13 - $90.25 $4.8 Million - $6 Million	-66,494 Reduced 46.14%	77,604 $6.87 Million
Q3 2019 Oct 29, 2019	BUY	$62.98 - $75.72 $3.34 Million - $4.02 Million	53,070 Added 58.3%	144,098 $10.7 Million
Q2 2019 Jul 17, 2019	BUY	$65.7 - $83.98 $451,359 - $576,942	6,870 Added 8.16%	91,028 $6.38 Million
Q1 2019 Apr 29, 2019	BUY	$77.14 - $90.79 $5.89 Million - $6.93 Million	76,308 Added 972.08%	84,158 $6.73 Million
Q4 2018 Jan 29, 2019	SELL	$77.85 - $96.01 $9.52 Million - $11.7 Million	-122,256 Reduced 93.97%	7,850 $708,000
Q3 2018 Oct 23, 2018	SELL	$88.91 - $98.84 $2.03 Million - $2.25 Million	-22,780 Reduced 14.9%	130,106 $12.2 Million
Q2 2018 Jul 17, 2018	SELL	$89.78 - $106.23 $4.76 Million - $5.64 Million	-53,066 Reduced 25.77%	152,886 $14.3 Million
Q1 2018 May 02, 2018	SELL	$92.01 - $123.21 $3.15 Million - $4.21 Million	-34,190 Reduced 14.24%	205,952 $19.3 Million
Q4 2017 Jan 26, 2018	BUY	$89.56 - $98.21 $8.98 Million - $9.85 Million	100,287 Added 71.71%	240,142 $23.6 Million
Q3 2017 Nov 06, 2017	BUY	$69.85 - $89.22 $9.77 Million - $12.5 Million	139,855	139,855 $12.5 Million

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $304B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meag Munich Ergo, Kapitalanlagegesellschaft Mb H, based on Form 13F filings with the SEC.

News

Stay updated on Meag Munich Ergo, Kapitalanlagegesellschaft Mb H with notifications on news.

Account

Meag Munich Ergo, Kapitalanlagegesellschaft Mb H Abb Vie Inc. Transaction History